OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates
OptimizeRx (OPRX) delivered earnings and revenue surprises of +1,300.00% and +7.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?